CTI
GILD icon

Community Trust & Investment’s Gilead Sciences GILD Stock Holding History

Community Trust & Investment’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-125,451
Closed -$10.5M – 107
2016
Q2 		$10.5M Buy
125,451
+23,915
+24% +$2.12M 1.33% 33
2016
Q1 		$9.33M Buy
101,536
+36,874
+57% +$3.33M 1.2% 38
2015
Q4 		$6.54M Buy
64,662
+33,098
+105% +$3.44M 0.86% 41
2015
Q3 		$3.1M Buy
+31,564
New +$3.51M 0.42% 50

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Community Trust & Investment's GILD Position: Q3 2016 in Review

Community Trust & Investment sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 125,451 shares — an estimated $10.5M sold.

Community Trust & Investment first reported a position in GILD in Q3 2015 and held it in 4 quarters. The position peaked at $10.5M in Q2 2016. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Community Trust & Investment reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Community Trust & Investment sold 125,451 Gilead Sciences shares in Q3 2016, an estimated $10.5M.
  • Community Trust & Investment first reported a position in Gilead Sciences in Q3 2015 and held it in 4 quarters.
  • Community Trust & Investment's Gilead Sciences position peaked at $10.5M in Q2 2016.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Community Trust & Investment's 13F filing for Q3 2016, filed 11 Oct 2016.